QTLs in Region (mRatBN7.2)
| 1576314 | Eutr1 | Estrogen induced uterine response QTL 1 | | | uterus integrity trait (VT:0010575) | pyometritis severity score (CMO:0002009) | 5 | 2138965 | 166875058 | Rat |
| 1641912 | Alcrsp18 | Alcohol response QTL 18 | | | response to alcohol trait (VT:0010489) | duration of loss of righting reflex (CMO:0002289) | 5 | 35189153 | 141643988 | Rat |
| 1549845 | Scl44 | Serum cholesterol level QTL 44 | 6 | | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 40128307 | 148607290 | Rat |
| 1578766 | Tcas11 | Tongue tumor susceptibility QTL 11 | 4.12 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 5 | 46711509 | 161317411 | Rat |
| 1576312 | Emca8 | Estrogen-induced mammary cancer QTL 8 | 4.1 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 5 | 50328551 | 141643988 | Rat |
| 61426 | Scl2 | Serum cholesterol level QTL 2 | 7.3 | 0.001 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 59793399 | 143070159 | Rat |
| 61393 | Bp7 | Blood pressure QTL 7 | 4.5 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 60293434 | 161481680 | Rat |
| 1354598 | Srn6 | Serum renin concentration QTL 6 | 3.8 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 5 | 69540295 | 151018848 | Rat |
| 1302790 | Scl20 | Serum cholesterol level QTL 20 | 6.4 | 0.0001 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 82394392 | 166664054 | Rat |
| 61452 | Ciaa5 | CIA Autoantibody QTL 5 | 3.5 | | blood autoantibody amount (VT:0003725) | calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) | 5 | 94858972 | 143070159 | Rat |
| 1331796 | Thshl2 | Thyroid stimulating hormone level QTL 2 | 2.3 | | blood thyroid-stimulating hormone amount (VT:0005119) | serum thyroid stimulating hormone level (CMO:0001248) | 5 | 97059760 | 147465714 | Rat |
| 1358187 | Emca1 | Estrogen-induced mammary cancer QTL 1 | 4.4 | | mammary gland integrity trait (VT:0010552) | post-insult time to mammary tumor formation (CMO:0000345) | 5 | 99216724 | 148607142 | Rat |
| 1578673 | Bmd13 | Bone mineral density QTL 13 | 4.9 | | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 5 | 103689353 | 148689353 | Rat |
| 2317056 | Wbc3 | White blood cell count QTL 3 | 2.51 | 0.01 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 5 | 105999803 | 150999803 | Rat |
| 7207488 | Bss110 | Bone structure and strength QTL 1 | 8.4 | | femur strength trait (VT:0010010) | femur stiffness (CMO:0001674) | 5 | 106906205 | 151906205 | Rat |
| 7207491 | Bss112 | Bone structure and strength QTL 112 | 7 | | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 5 | 106906205 | 151906205 | Rat |
| 7207481 | Bss106 | Bone structure and strength QTL 106 | 7.9 | | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 106906205 | 151906205 | Rat |
| 7207486 | Bss109 | Bone structure and strength QTL 109 | | | femur strength trait (VT:0010010) | femur total energy absorbed before break (CMO:0001677) | 5 | 106906205 | 151906205 | Rat |
| 1549838 | Bss4 | Bone structure and strength QTL 4 | 9.2 | | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 5 | 106906205 | 151906205 | Rat |
| 1298089 | Scl14 | Serum cholesterol level QTL 14 | 5.8 | 0.0004 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 108845856 | 153845856 | Rat |
| 1598847 | Cm62 | Cardiac mass QTL 62 | 3.4 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 108845856 | 153845856 | Rat |
| 8657050 | Bw146 | Body weight QTL 146 | 19.84 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 108938288 | 153938288 | Rat |
| 8694441 | Bw169 | Body weight QTL 169 | 17.61 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 5 | 111416838 | 156416838 | Rat |
| 8694198 | Abfw3 | Abdominal fat weight QTL 3 | 16.13 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 5 | 111416838 | 156416838 | Rat |
| 8694389 | Bw160 | Body weight QTL 160 | 6.17 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 5 | 111416838 | 156416838 | Rat |
| 8552960 | Pigfal15 | Plasma insulin-like growth factor 1 level QTL 15 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 111416838 | 156416838 | Rat |
| 1581510 | Cm54 | Cardiac mass QTL 54 | 3.4 | 0.05 | heart left ventricle mass (VT:0007031) | heart left ventricle weight to body weight ratio (CMO:0000530) | 5 | 120740824 | 143608494 | Rat |
| 2293642 | Bss37 | Bone structure and strength QTL 37 | 4.64 | 0.0001 | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 120740824 | 151018848 | Rat |
| 1641920 | Colcs1 | Colorectal carcinoma susceptibility QTL 1 | 2.99 | 0.0055 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 5 | 121846814 | 166846814 | Rat |
| 10053720 | Scort26 | Serum corticosterone level QTL 26 | 2.06 | 0.0147 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 5 | 124965598 | 166875058 | Rat |
| 1300122 | Wbc1 | White blood cell count QTL 1 | 2.75 | | leukocyte quantity (VT:0000217) | total white blood cell count (CMO:0000365) | 5 | 125392826 | 139989768 | Rat |
| 724525 | Bp147 | Blood pressure QTL 147 | 4.3 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 126424772 | 166875058 | Rat |
| 1598819 | Bp292 | Blood pressure QTL 292 | 4.3 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 127798274 | 166875058 | Rat |
| 1598861 | Cm64 | Cardiac mass QTL 64 | 2.9 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 127798274 | 166875058 | Rat |
| 8552908 | Pigfal4 | Plasma insulin-like growth factor 1 level QTL 4 | 6.6 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 128506074 | 166875058 | Rat |
| 8694169 | Bw148 | Body weight QTL 148 | 5 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 128506074 | 166875058 | Rat |
| 634349 | Bp139 | Blood pressure QTL 139 | | 0.001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 128924607 | 166875058 | Rat |
| 1331803 | Rf32 | Renal function QTL 32 | 2.798 | | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 5 | 129132428 | 143070159 | Rat |
| 70156 | Niddm30 | Non-insulin dependent diabetes mellitus QTL 30 | 3.98 | | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 5 | 129132447 | 151006154 | Rat |
| 738018 | Anxrr4 | Anxiety related response QTL 4 | 5.1 | | exploratory behavior trait (VT:0010471) | percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) | 5 | 130130159 | 166875058 | Rat |
| 7794791 | Mcs33 | Mammary carcinoma susceptibility QTL 33 | 1.93 | | mammary gland integrity trait (VT:0010552) | mammary tumor incidence/prevalence measurement (CMO:0000946) | 5 | 131345754 | 166875058 | Rat |
| 631505 | Bp103 | Blood pressure QTL 103 | 3.2 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 132717196 | 165560427 | Rat |
| 631562 | Apr2 | Acute phase response QTL 2 | 3.7 | | blood murinoglobulin 1 amount (VT:0010597) | plasma murinoglobulin 1 level (CMO:0001931) | 5 | 135927956 | 166875058 | Rat |
| 61444 | Strs2 | Sensitivity to stroke QTL 2 | 4.7 | | cerebrum integrity trait (VT:0010549) | post-insult time to onset of cerebrovascular lesion (CMO:0002343) | 5 | 135929696 | 166875058 | Rat |
| 2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 5214602 | 146446691 | Rat |
| 2316958 | Gluco58 | Glucose level QTL 58 | 10 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 11320076 | 180699135 | Rat |
| 1358352 | Srcrt3 | Stress Responsive Cort QTL 3 | 2.29 | | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 38465774 | 146803430 | Rat |
| 1576305 | Emca6 | Estrogen-induced mammary cancer QTL 6 | 5.8 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 4 | 44463720 | 155883716 | Rat |
| 1354612 | Foco1 | Food consumption QTL 1 | 8.87 | | eating behavior trait (VT:0001431) | food intake rate (CMO:0000427) | 4 | 44463908 | 148090542 | Rat |
| 1354660 | Salc1 | Saline consumption QTL 1 | 11.26 | | drinking behavior trait (VT:0001422) | saline drink intake rate (CMO:0001627) | 4 | 44463908 | 148090542 | Rat |
| 2312567 | Glom19 | Glomerulus QTL 19 | 1.9 | 0.006 | kidney glomerulus morphology trait (VT:0005325) | index of glomerular damage (CMO:0001135) | 4 | 45456990 | 146803430 | Rat |
| 1298082 | Stresp4 | Stress response QTL 4 | | | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 50119848 | 146803430 | Rat |
| 70200 | Alc18 | Alcohol consumption QTL 18 | 9.2 | | drinking behavior trait (VT:0001422) | ethanol intake volume to total fluid intake volume ratio (CMO:0001591) | 4 | 56647873 | 149491524 | Rat |
| 1641833 | Alc21 | Alcohol consumption QTL 21 | 8.6 | 0.0001 | drinking behavior trait (VT:0001422) | ethanol drink intake rate (CMO:0001407) | 4 | 56698790 | 126192555 | Rat |
| 738009 | Sach4 | Saccharine consumption QTL 4 | 4.9 | 0.000016 | consumption behavior trait (VT:0002069) | saccharin intake volume to total fluid intake volume ratio (CMO:0001601) | 4 | 59948935 | 154902892 | Rat |
| 738016 | Alc16 | Alcohol consumption QTL 16 | 3.6 | 0.00015 | consumption behavior trait (VT:0002069) | ethanol drink intake rate to body weight ratio (CMO:0001616) | 4 | 59948935 | 154902892 | Rat |
| 738031 | Alc14 | Alcohol consumption QTL 14 | 7.6 | 0.00003 | consumption behavior trait (VT:0002069) | ethanol drink intake rate to body weight ratio (CMO:0001616) | 4 | 59948935 | 154902892 | Rat |
| 61418 | Pia5 | Pristane induced arthritis QTL 5 | 4.5 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 62277855 | 128289560 | Rat |
| 631674 | Iddm14 | Insulin dependent diabetes mellitus QTL 14 | | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 4 | 64528739 | 157573521 | Rat |
| 61330 | Eau1 | Experimental allergic uveoretinitis QTL 1 | | 0.0003 | uvea integrity trait (VT:0010551) | experimental autoimmune uveitis score (CMO:0001504) | 4 | 70362013 | 132642728 | Rat |
| 631646 | Stl4 | Serum triglyceride level QTL 4 | 6.5 | 0.0001 | blood triglyceride amount (VT:0002644) | plasma triglyceride level (CMO:0000548) | 4 | 73169846 | 132642728 | Rat |
| 724522 | Bp146 | Blood pressure QTL 146 | 2.2 | 0.0021 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 73630210 | 118630210 | Rat |
| 2302051 | Pia28 | Pristane induced arthritis QTL 28 | 5.3 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112) | 4 | 73630210 | 118630210 | Rat |
| 631662 | Hcar2 | Hepatocarcinoma resistance QTL 2 | 3.1 | 0.0003 | liver integrity trait (VT:0010547) | volume of individual liver tumorous lesion (CMO:0001078) | 4 | 78878504 | 123878504 | Rat |
| 738015 | Pia9 | Pristane induced arthritis QTL 9 | 4.5 | 0.048 | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 80694870 | 125694870 | Rat |
| 2306899 | Bp338 | Blood pressure QTL 338 | | 0.071 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 81006124 | 120102625 | Rat |
| 1641919 | Alc22 | Alcohol consumption QTL 22 | | 0.0005 | drinking behavior trait (VT:0001422) | ethanol drink intake rate (CMO:0001407) | 4 | 81192555 | 126192555 | Rat |
| 70177 | Xhs1 | X-ray hypersensitivity QTL 1 | 25.1 | | intestine integrity trait (VT:0010554) | post-insult time to onset of moribundity (CMO:0001896) | 4 | 82798864 | 152731274 | Rat |
| 1576316 | Ept5 | Estrogen-induced pituitary tumorigenesis QTL 5 | 3.8 | | pituitary gland mass (VT:0010496) | pituitary gland wet weight (CMO:0000853) | 4 | 83428419 | 177635233 | Rat |
| 634334 | Xhs3 | X-ray hypersensitivity QTL 3 | 10 | | intestine integrity trait (VT:0010554) | post-insult time to onset of moribundity (CMO:0001896) | 4 | 84728680 | 129854654 | Rat |
| 1582232 | Gluco25 | Glucose level QTL 25 | 3.6 | 0.0023 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 85253748 | 148090731 | Rat |
| 12798523 | Anxrr56 | Anxiety related response QTL 56 | 2.83 | 0.05 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 85253748 | 150276390 | Rat |
| 1358202 | Gluco11 | Glucose level QTL 11 | 2.4 | 0.02 | adipocyte glucose uptake trait (VT:0004185) | absolute change in adipocyte glucose uptake (CMO:0000873) | 4 | 85379421 | 167139601 | Rat |
| 61476 | Aia3 | Adjuvant induced arthritis QTL 3 | 3.9 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 86730991 | 131730991 | Rat |
| 1578662 | Bss15 | Bone structure and strength QTL 15 | 19.6 | | femur width (VT:1000666) | femoral neck width (CMO:0001695) | 4 | 87327165 | 132327165 | Rat |
| 1578670 | Bss14 | Bone structure and strength QTL 14 | 16.4 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 4 | 87327165 | 132327165 | Rat |
| 1578655 | Bmd11 | Bone mineral density QTL 11 | 11 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 4 | 90850165 | 135850165 | Rat |
| 634335 | Anxrr16 | Anxiety related response QTL 16 | 7.22 | | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 4 | 93308457 | 167139447 | Rat |
| 631689 | Scl4 | Serum cholesterol level QTL 4 | 1.9 | 0.008 | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 4 | 95174120 | 140174120 | Rat |
| 61434 | Cia3 | Collagen induced arthritis QTL 3 | 4.8 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 103194656 | 148194656 | Rat |
| 2302049 | Pia32 | Pristane induced arthritis QTL 32 | 5.1 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112) | 4 | 105789505 | 150789505 | Rat |
| 731165 | Uae21 | Urinary albumin excretion QTL 21 | 2.4 | 0.0001 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 4 | 106649412 | 151649412 | Rat |
| 61406 | Scwia1 | Streptococcal cell wall induced arthritis QTL 1 | 2.3 | | joint integrity trait (VT:0010548) | experimental arthritis severity measurement (CMO:0001459) | 4 | 106805662 | 151805662 | Rat |
| 7207480 | Bss105 | Bone structure and strength QTL 105 | 8.1 | | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 4 | 109827074 | 154827074 | Rat |
| 1549832 | Bss3 | Bone structure and strength QTL 3 | 11 | | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 4 | 109827074 | 154827074 | Rat |
| 737821 | Hcar9 | Hepatocarcinoma resistance QTL 9 | 3.7 | | liver integrity trait (VT:0010547) | volume of individual liver tumorous lesion (CMO:0001078) | 4 | 109866907 | 167139601 | Rat |
| 1331759 | Hrtrt13 | Heart rate QTL 13 | 3.54628 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 4 | 110275411 | 168266883 | Rat |
| 6478760 | Anxrr45 | Anxiety related response QTL 45 | | 0.06717 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 110870972 | 155870972 | Rat |
| 6478763 | Anxrr46 | Anxiety related response QTL 46 | | 0.07428 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 110870972 | 155870972 | Rat |
| 12798519 | Anxrr54 | Anxiety related response QTL 54 | 2.54 | 0.05 | locomotor behavior trait (VT:0001392) | distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493) | 4 | 114627026 | 159627026 | Rat |
| 1300116 | Hrtrt5 | Heart rate QTL 5 | 3.76 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 4 | 116179486 | 151161268 | Rat |
